Point72 Hong Kong LTD Uni Qure N.V. Transaction History
Point72 Hong Kong LTD
- $1.34 Billion
- Q2 2025
A detailed history of Point72 Hong Kong LTD transactions in Uni Qure N.V. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 1,465 shares of QURE stock, worth $93,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,465Holding current value
$93,642% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding QURE
# of Institutions
193Shares Held
51.8MCall Options Held
4.43MPut Options Held
1.27M-
Rtw Investments, LP New York, NY5.16MShares$330 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$255 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$237 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$232 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$176 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $2.99B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...